Reliability of the ABC/2 Method in Determining Acute Infarct Volume

Journal of Neuroimaging

Volumn 22, Issue 2, 2012, Pages 155-159

  Pedraza, Salvador ^a,c   Puig, Josep ^a   Blasco, Gerard ^a   Daunis i Estadella, Josep ^a   Boada, Imma ^a   Bardera, Anton ^a   Castellanos, Mar ^b   Serena, Joaquín ^b  

^a UNIVERSITY OF GIRONA   (Spain)

^b HOSPITAL JOSEP TRUETA   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Infarct; Stroke; Volume

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFUSION WEIGHTED IMAGING; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MENTAL DETERIORATION; NUCLEAR MAGNETIC RESONANCE IMAGING; REPRODUCIBILITY; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN ISCHEMIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; STROKE;

EID: 84859727680     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2011.00588.x     Document Type: Article

References (25)

1. The NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute stroke. N Engl J Med 1995;333:1581-1587.
2. Pedraza S, Puig J, Remollo S, et al. Magnetic resonance imaging in the diagnosis of stroke. G Expert Opin Med Diagn 2008;2(7):1-10.
3. Pedraza S, Puig J, Blasco G, et al. Imaging biomarkers on ischemic stroke. Validation criteria of primary imaging biomarkers. Drug News Perspect 2009;22(8):1-6.
4. Van Der Worp HB, Claus SP, Bär PR, et al. Reproducibility of measurements of cerebral infarct volume on CT scans. Stroke 2001;32(2):424-430.
5. Oppenheim C, Samson Y, Manaï R, et al. Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 2000;31:2175-2181.
6. Lansberg MG, Thijs VN, Bammer R, et al. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007;38:2275-2278.
7. Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998;29:1888-1893.
8. Albers GW, Thijs VN, Wechsler L, et al. DEFUSE Investigators l. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (defuse) study. Ann Neurol 2006;60:508-517.
9. Hacke W, Albers G, Al-Rawi et al. DIAS Study Group. The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66-73.
10. Davis SM, Donnan GA, Parsons MW, et al. EPITHET investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008;7:299-309.
11. Warach S, Pettigrew LC, Dashe JF, et al. Effect of citicoline on ischemic lesions as measured by diffusion weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol 2000;48:713-722.
12. Rivers CS, Wardlaw JM, Armitage PA, et al. Do acute diffusion- and perfusion-weighted MRI lesions identify final infarct volume in ischemic stroke Stroke 2006;37:98-104.
13. Beaulieu C, de Crespigny A, Tong DC, et al. Longitudinal magnetic resonance imaging study of perfusion and diffusion in stroke: evolution of lesion volume and correlation with clinical outcome. Ann Neuro 1999;46:568-578.
14. Sims JR, Gharai LR, Schaefer PW, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009;72:2104-2110.
15. Newman GC. Clarification of abc/2 Rule for ICH volume. Stroke 2007;38:862-863.
16. Pantano P, Carmaia F, Bozaao L, et al. Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome. Stroke 1999;30:502-507.
17. Castillo J, Davalos A, Marrugat J, et al. Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998;29:2455-2460.
18. Gomez-Mariño R, André C, Novis SAP. Determinaçao volumétrica do infarto cerebral na fase aguda usando tomografía computarizada de cranio sem contraste. Arq Neuropsiquiatr 2001;59(2-8):380-383.
19. Clark WM, Albers GW, Madden KP, et al. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g): results of a double-blind, placebo-controlled, multicenter study. Stroke 2000;31:811-816.
20. Jensen MB, Chacon MR, Sattin JA, et al. Potential biomarkers for the diagnosis of stroke. Expert Rev Cardiovasc Ther 2009;7(4):389-393.
21. Castellanos M, Serena J. Applicability of biomarkers in ischemic stroke. Cerebrovasc Dis 2007;24(Suppl 1):7-15.
22. Castellanos M, Sobrino T, Pedraza S, et al. High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke. Neurology 2008;71(23):1862-1868.
23. Wintermark M, Albers GW, Alexandrov AV, et al. Acute stroke imaging research roadmap. Stroke 2008;39:1621-1628.
24. Straka M, Albers GW, Bammer R. Real time diffusion-perfusion mismatch analysis in acute stroke. J Magn Reson Imaging 2010;32:1024-1037.
25. Leiva-Salinas C, Wintermark M. The future of stroke imaging: what we need and how to get to It. Stroke 2010;41:S152-S153.